Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $1.5B bought by 340 insiders at 207 companies
- $3.2B sold by 266 insiders outside a trading plan
- $7.9B sold by 826 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month, each insider's filings added up.
-
LENLennarBerkshire Hathaway Inc.10% owner, +1 joint filer$383M
-
CRBGCorebridge FinancialLife Insurance Co Nippon10% owner$225M
-
KODKodiak SciencesBaker Bros. Advisors LPDirector, +5 joint filers$157M
-
SAFXXCF GlobalEEME Energy SPV I, LLC10% owner$142M
-
GPIGroup 1 AutomotiveConifer Management, L.L.C.10% owner$97.8M
-
UUUUniversal Safety ProductsMilton C Ault IIIDirector$92.5M
-
GMEGameStopRyan CohenCEO$50.4M
-
BORRBorr DrillingTor Olav TroimDirector$43M
-
PAMPampa EnergiaMarcos Marcelo MindlinDirector$35.1M
-
GGRGogoroChung-Yao YinDirector$35.1M
Biggest sales
Past month, each insider's filings added up. Planned sales are marked.
-
IHTInnSuites Hospitality TrustJames F WirthCEO$4.2B
-
MDLNMedlineGIC Private Ltd10% owner, +2 joint filers$996M
-
ESTCElasticSteven SchuurmanDirector$323M
-
TALOTalos EnergyEmpresarial De Capitales S.a. De C.v. Control10% owner$253M
-
AVGOBroadcomHenry SamueliDirector$250M
-
THTarget HospitalityTDR Capital II Investments LP10% owner, +9 joint filers$202M
-
ANETArista NetworksJayshree UllalCEO$166M
-
KNTKKinetikISQ Global Fund II GP LLC10% owner, +4 joint filers$134M
-
CRWDCrowdStrikeBurt W. PodbereCFO$125M
-
NBISNebius GroupOphir NaveCOO$118M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days, most buyers first
-
Che-Chia Wei CEO, Yuh-Jier Mii COO, Yung-Pei Chin COO, Yung-Chin Hou COO, +15 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
R Jeffrey Bailly Director, Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, +5 more
-
Steven M Paul Director, John Maraganore Director, Troy A. Ignelzi CFO, Wendy B. Young Director, +1 more
-
Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more
-
John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more
-
Michael Jordan Osborn CEO, John Walter Hazlett CFO, Gregory William Voorhies Director, James W Bernau President, +1 more
-
Matthew G De Soto Director, Albert J. Evans Director, Kimberly J Brumbaugh Director, Theodore W Mowery Director, +1 more
-
Smriti Laxman Popenoe CEO, Byron L Boston CEO, Terrence John Connelly Jr. Chief Investment Officer, Michael Andrew Sartori CFO
-
Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director
All insider trades
Every open-market buy and sale, one row per filing, newest first
-
Bin Zhao CEOAPIAgoraBuy$168K 38,267 shares at $4.40 +1.8% to stakeTraded Oct 19–22 Filed Oct 22
-
James F Wirth CEOIHTInnSuites Hospitality TrustPlanned sale$2B 43,111 shares at $46,654.38 0.5% of stakeTraded Oct 20 Filed Oct 22
-
Anne Kuykendall SVP and Chief Legal OfficerPENGPenguin SolutionsPlanned sale$41K 738 shares at $55.08 0.5% of stakeTraded Oct 22 Filed Oct 22
-
Ryoji Sekido CEOACNAccentureSale$1.4M 5,844 shares at $244.84 83% of stakeTraded Oct 22 Filed Oct 22
-
Kelli Keough EVP, Gbul, SipsSOFISoFi TechnologiesPlanned sale$150K 10,203 shares at $14.72 2.5% of stakeTraded Oct 20 Filed Oct 22
-
Melissa A Burgum Chief Accounting OfficerACNAccenturePlanned sale$203K 811 shares at $250.00 7.6% of stakeTraded Oct 22 Filed Oct 22
-
Peyton Boswell DirectorLIQTLiqTech InternationalBuy$50K 50,000 shares at $1.00 +41% to stakeTraded Jun 5 Filed Oct 22
-
Kenneth Duda President and CTOANETArista NetworksPlanned sale$7.8M 43,333 shares at $180.91Traded Oct 20 Filed Oct 22
-
Brady Brewer ceo, InternationalSBUXStarbucksPlanned sale$59K 588 shares at $100.00 0.8% of stakeTraded Oct 20 Filed Oct 22
-
Glenbrook Capital Management 10% ownerSNESSenesTechBuy$75K 103,875 shares at $0.7200Traded Oct 20–22 Filed Oct 22
-
Eric Venker CEOROIVRoivant SciencesPlanned sale$7M 200,000 shares at $35.11 13% of stakeTraded Oct 20 Filed Oct 22
-
Anthony Mathew Eisen DirectorXYZBlockPlanned sale$1.4M 18,000 shares at $78.13 1.4% of stakeTraded Oct 20–22 Filed Oct 22
-
Pale Fire Capital SE 10% owner, +4 joint filersDOLEDole PLCBuy$8.6M 648,356 shares at $13.19 +6.7% to stakeTraded Oct 20–22 Filed Oct 22
-
Sven-Olof Lindblad DirectorLINDLindblad ExpeditionsPlanned sale$8.6M 240,989 shares at $35.85 2.3% of stakeTraded Oct 20–22 Filed Oct 22
-
Jennifer Newstead SVP, GC and Government AffairsAAPLApplePlanned sale$815K 2,399 shares at $339.62 6.4% of stakeTraded Oct 20 Filed Oct 22
-
Patricia Gallup Chair, +1 joint filerCNXNPC ConnectionPlanned sale$1.3M 15,196 shares at $86.87 0.2% of stakeTraded Oct 20–21 Filed Oct 22
-
Cynthia L Tregillis Chief Legal Officer & Corp SecWDCWestern DigitalPlanned sale$307K 807 shares at $380.00 0.7% of stakeTraded Oct 21 Filed Oct 22
-
Henry Edward Dubois CFOBKSYBlackSky TechnologyPlanned sale$67K 4,000 shares at $16.85 0.8% of stakeTraded Oct 20 Filed Oct 22
-
Brian E O'Toole CEOBKSYBlackSky TechnologyPlanned sale$337K 20,000 shares at $16.86 1.9% of stakeTraded Oct 20 Filed Oct 22
-
Christiana L Lin General Counsel & CAOBKSYBlackSky TechnologyPlanned sale$101K 6,000 shares at $16.86 1.4% of stakeTraded Oct 20 Filed Oct 22
-
Amit Kumar CEOANIXAnixa BiosciencesBuy$22K 8,000 shares at $2.72 +1.2% to stakeTraded Oct 22 Filed Oct 22
-
Teresa Hillary Clarke DirectorAMTAmerican TowerBuy$64K 338 shares at $188.38 +6.4% to stakeTraded Apr 28, 2023–Oct 20 Filed Oct 22
-
Martin J Gepsman DirectorCMECME GroupSale$121K 400 shares at $302.50 1.6% of stakeTraded Oct 22 Filed Oct 22
-
Matthew Neagle COOPRCHPorch GroupPlanned sale$563K 31,250 shares at $18.01 1.7% of stakeTraded Oct 20 Filed Oct 22
-
John D Gottwald 10% ownerTGTredegarSale$268K 33,333 shares at $8.03 10% of stakeTraded Oct 20 Filed Oct 22
-
William M Gottwald 10% ownerTGTredegarSale$268K 33,334 shares at $8.03 10% of stakeTraded Oct 20 Filed Oct 22
-
Jonathan Hyman Chief Technology OfficerBRZEBrazePlanned sale$13.2M 295,000 shares at $44.81 26% of stakeTraded Oct 15–20 Filed Oct 22
-
Toby R Neugebauer 10% owner, +1 joint filerFRMIFermiSale$1.3M 420,749 shares at $3.04 0.5% of stakeTraded Oct 20 Filed Oct 22
-
Astha Malik Chief Business OfficerBRZEBrazePlanned sale$465K 15,724 shares at $29.57 6.1% of stakeTraded Aug 19 Filed Oct 22
-
Fiona Tan Chief Technology OfficerWWayfairPlanned sale$920K 8,000 shares at $115.00 3.9% of stakeTraded Oct 20 Filed Oct 22
-
Life Insurance Co Nippon 10% ownerCRBGCorebridge FinancialBuy$6.8M 193,357 shares at $35.01 +0.1% to stakeTraded Oct 20 Filed Oct 22
-
Paul M Silva DirectorRAPPRapport TherapeuticsBuy$100K 3,680 shares at $27.08 New stakeTraded Oct 22 Filed Oct 22
-
Wendy B. Young DirectorRAPPRapport TherapeuticsBuy$100K 3,789 shares at $26.39 +40% to stakeTraded Oct 22 Filed Oct 22
-
Steven M Paul DirectorRAPPRapport TherapeuticsBuy$974K 35,714 shares at $27.28 +86% to stakeTraded Oct 22 Filed Oct 22
-
Scott A Werth SVP StoresBKEBuckleSale$117K 2,500 shares at $46.75 5.1% of stakeTraded Oct 22 Filed Oct 22
-
John Maraganore DirectorRAPPRapport TherapeuticsBuy$249K 9,411 shares at $26.45 New stakeTraded Oct 22 Filed Oct 22
-
John Joseph Giamatteo CEOBBBlackBerrySale$2.3M 250,000 shares at $9.14 32% of stakeTraded Oct 21–22 Filed Oct 22
-
Kathleen L. Patterson Chief HR & Corp CitizenshipALLYAlly FinancialSale$496K 12,831 shares at $38.65 16% of stakeTraded Oct 21 Filed Oct 22
-
Gary K. Schick SVP, CHROJBLJabilPlanned sale$277K 1,000 shares at $277.16 2.6% of stakeTraded Oct 20 Filed Oct 22
-
Todd P. Kelsey CEOPLXSPlexusPlanned sale$359K 1,500 shares at $239.16 2.3% of stakeTraded Oct 21 Filed Oct 22
-
Ryan A King FounderCHYMChime FinancialPlanned sale$351K 11,318 shares at $31.03 23% of stakeTraded Oct 20 Filed Oct 22
-
Martine A Rothblatt CEOUTHRUnited TherapeuticsPlanned sale$5.3M 9,500 shares at $560.07 2.8% of stakeTraded Oct 21 Filed Oct 22
-
Richmond Y Holden Jr. DirectorACUAcme UnitedSale$21K 341 shares at $62.01 2% of stakeTraded Oct 9 Filed Oct 22
-
Traci S Umberger See RemarksKMTSKestra Medical TechnologiesPlanned sale$2.7M 100,000 shares at $27.18 34% of stakeTraded Oct 21 Filed Oct 22
-
Brian Daniel Webster See RemarksKMTSKestra Medical TechnologiesPlanned sale$443K 15,000 shares at $29.56 3.3% of stakeTraded Oct 20 Filed Oct 22
-
Vivek Narayanadas General Counsel & SecretaryOKLOOklo Inc.Planned sale$27K 1,021 shares at $26.50 8.7% of stakeTraded Oct 20 Filed Oct 22
-
Dennis Polk ChairSNXTD SYNNEXSale$994K 3,955 shares at $251.27 16% of stakeTraded Oct 21 Filed Oct 22
-
Garrett L. Chase CFOVSATViaSatPlanned sale$235K 4,000 shares at $58.86 7.8% of stakeTraded Oct 20 Filed Oct 22
-
Mac Armstrong CEOPLMRPalomarPlanned sale$484K 3,500 shares at $138.31 1.1% of stakeTraded Oct 21 Filed Oct 22
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,838 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.